Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication for the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2025 is enclosed herewith.
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience Limited has submitted a copy of the newspaper publication of its unaudited financial results for the quarter and half year ended September 30, 2025. This is a routine regulatory compliance filing under SEBI's Listing Obligations and Disclosure Requirements (LODR), which mandates companies to publish their quarterly/half-yearly financial results in newspapers. The actual financial results have already been filed with the exchanges through a prior announcement.
This is a procedural compliance filing with no direct impact on shareholders or stock price. Investors should refer to the original Q2/H1 FY26 results announcement for actual financial performance details.